Latest News

In recent months, Goodyear Tire & Rubber has moved ahead with its Goodyear Forward program, completing roughly US$2.20 billion of divestitures to cut debt while continuing premium product launches and OEM partnerships. These debt-reduction moves are reshaping Goodyear from a traditionally cyclical tire maker into a more focused, self-help story centered on higher-margin core operations and cost savings. Next, we’ll examine how Goodyear’s asset sales and deleveraging push interact with its...

Wave Life Sciences (WVE) has quietly delivered powerful gains this year, with the stock up roughly 39% year to date and more than tripling over the past 3 years. See our latest analysis for Wave Life Sciences. That surge in 1 week share price return of about 165 percent has turned heads, and with a 3 year total shareholder return nearing 287 percent, momentum now looks firmly in Wave’s favor as investors reassess its growth runway and risk profile. If Wave’s recent jump has you thinking more...

EQT (OM:EQT) has quietly added another month of gains, with the stock up around 3 % over the past month and roughly 6 % year to date, outpacing many European financial names. See our latest analysis for EQT. With the share price now at SEK 327.9 and a 30 day share price return of 2.76 % feeding into a 6.05 % year to date gain, EQT’s three year total shareholder return of 43.21 % suggests momentum is still broadly intact rather than fading. If EQT’s run has you thinking about what else might...

Nu Holdings (NYSE:NU) is back in the spotlight after fresh data highlighted how its tech driven banking model in Latin America is still translating into rising profits and better unit economics, sharpening focus on what the stock is truly worth. See our latest analysis for Nu Holdings. That optimism has not gone unnoticed in the market, with Nu’s share price up a strong year to date on the back of consistent earnings beats and expanding margins. At the same time, recent pullbacks suggest some...

In recent days, Cinemark Holdings reported a weak third quarter, with net income and revenue falling, just as Netflix’s planned acquisition of Warner Bros Discovery raised fresh questions about the future of theatrical release windows for major films. Together, the earnings disappointment and uncertainty around how a combined Netflix–Warner Bros Discovery might prioritize streaming versus theaters are forcing investors to reassess how durable Cinemark’s traditional cinema model may be. Next,...

QCR Holdings (QCRH) just delivered a standout Q3, with revenue and earnings comfortably ahead of Wall Street estimates. The stock has climbed about 20% since, signaling renewed investor conviction in this regional bank. See our latest analysis for QCR Holdings. That upbeat Q3 has capped a strong run, with a 1 month share price return of 13.44% and year to date share price gains contributing to a 3 year total shareholder return of 78.21%, suggesting momentum is building rather than fading. If...

Reinsurance Group of America (RGA) has quietly slipped about 2% over the past week and roughly 11% over the past year, even as its revenue and earnings continue to grow at a solid clip. See our latest analysis for Reinsurance Group of America. At around $188.64, the recent slide in RGA’s share price looks more like a pause than a breakdown. Short term share price pressure contrasts sharply with its robust multi year total shareholder returns, suggesting momentum is cooling but not broken. If...

Molson Coors Beverage recently reported that Madrí Excepcional has surpassed £1.00 billion in annual sales, becoming the UK’s second-largest world lager brand just five years after its launch, while its alcohol-free Madrí Excepcional 0.0% generated more than £1.50 million in revenue in its first six months. This rapid rise of Madrí Excepcional highlights how Molson Coors’ premium and low- or no-alcohol offerings can broaden its portfolio mix and support higher-margin, international...

If you are wondering whether Nestlé is quietly becoming good value again, or if it is still priced for safety rather than upside, you are not alone. Plenty of long term investors are asking the same question. The stock is up 4.9% year to date and 7.3% over the last year, but those gains sit against a 21.5% slide over 3 years and a 9.5% drop over 5 years, suggesting the market is still recalibrating its expectations. Recent months have seen Nestlé in the headlines for portfolio reshaping and...

Stronger earnings, softer reaction IHS Holding (NYSE:IHS) just posted third quarter 2025 earnings that blew past forecasts and raised its full year revenue outlook, yet the stock slipped in pre market trading as investors dug into the details. The company also laid out plans to expand further in Brazil and bring more AI into its operations, while signaling it may consider dividends or buybacks in the future. These moves could reshape how investors think about its growth and capital return...

Newron Pharmaceuticals has initiated its ENIGMA-TRS 2 global Phase III trial of evenamide as an add-on therapy for treatment-resistant schizophrenia, following US FDA and IRB approvals, with the first site at UCLA’s Semel Translational Research Center for Neuropsychiatry. The study’s focus on rigorously defined treatment-resistant patients and evenamide’s targeted sodium-channel mechanism highlights its potential differentiation from existing antipsychotic options. Next, we’ll explore how...

Nippon Shinyaku (TSE:4516) just caught investors’ attention after deramiocel cleared a key Phase 3 hurdle in Duchenne muscular dystrophy, prompting a JPMorgan upgrade that reframes the company’s long-term profit and pipeline story. See our latest analysis for Nippon Shinyaku. The deramiocel news has lit a fire under Nippon Shinyaku, with a 7 day share price return of 64.20 percent and a 30 day share price return of 82.37 percent, signalling rapidly building momentum despite a weaker 3 year...

Zeon (TSE:4205) has quietly delivered a 31% return over the past year, even as earnings growth has been mixed. That combination makes the latest move in Zeon stock worth a closer look. See our latest analysis for Zeon. With the share price now around ¥1,757.5, Zeon has shrugged off a soft patch earlier in the year. It has posted a solid 1 month share price return and a robust 1 year total shareholder return, suggesting momentum is gradually rebuilding as investors reassess its growth and risk...

In its latest update, The Greenbrier Companies reported fiscal Q4 orders for 2,400 railcars worth over US$300 million, delivered 4,900 units, and ended August 2025 with a backlog of 16,600 railcars valued at nearly US$2.20 billion. The company’s lease fleet expanded about 10% in fiscal 2025 with 98% utilization and it paid its 46th consecutive quarterly dividend on December 3, 2025, underscoring sustained demand for its equipment and services. We’ll now examine how this strong railcar...

Corning (GLW) is back on investors radar after its optical communications business again took center stage in the latest earnings update, with AI driven data center demand powering a meaningful jump in sales and profit contribution. See our latest analysis for Corning. That backdrop helps explain why Corning’s share price has climbed to about $88, with a powerful year to date share price return of roughly 89 percent and a three year total shareholder return above 180 percent, signaling...

Sumitomo (TSE:8053) just filed a ¥300 billion bond shelf registration, a move that puts fresh financing within easy reach and immediately raises questions about how management plans to deploy that firepower. See our latest analysis for Sumitomo. The move comes after a strong run for the stock, with a 47.2% year to date share price return and a 56.1% one year total shareholder return signaling momentum rather than fatigue. If Sumitomo’s financing plans have you thinking bigger picture, this is...

Bitfarms (TSX:BITF) has quietly become a high beta way to express a view on bitcoin, with the stock swinging from a strong past 3 months to a weaker recent month of trading. See our latest analysis for Bitfarms. Zooming out, that weak recent stretch comes after a powerful run. The 90 day share price return of 84.93 percent and three year total shareholder return of 495.59 percent suggest long term momentum is still very much intact despite short term volatility. If Bitfarms has you thinking...

Wolters Kluwer (ENXTAM:WKL) just rolled out SteuerSparErklärung Online in Germany, a browser based tax filing platform that uses its AI assistant Alma to simplify the entire return process for everyday users. See our latest analysis for Wolters Kluwer. Despite this kind of product innovation, Wolters Kluwer’s share price has had a tough stretch, with a steep year to date share price decline and weaker one year total shareholder return. However, the five year total shareholder return remains...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Liontown (ASX:LTR) has grabbed attention after signing a binding offtake deal with Canmax Technologies, locking in spodumene concentrate supply for 2027 and 2028 and deepening its ties into the global battery supply chain. See our latest analysis for Liontown. The market seems to like the story, with a 45.10% 1 month share price return and a 159.65% year to date share price return contributing to a 142.62% 1 year total shareholder return. This suggests strong momentum despite a weaker 3 year...

Barclays has taken a more constructive view on Compass, upgrading the stock after highlighting expected benefits from its HOUS acquisition, an improved pitch to agents, and potential upside as existing home sales gradually recover. See our latest analysis for Compass. That backdrop helps explain why momentum in Compass shares has been building, with a 21.87% 1 month share price return, a 79.66% year to date share price return, and a striking 294.70% 3 year total shareholder return, even...

PPG Industries (PPG) has been drifting lower this year, even as its latest annual results showed steady revenue and earnings growth. That disconnect is what has investors revisiting the coatings giant’s valuation today. See our latest analysis for PPG Industries. Despite a recent 1 month share price return of 4.28 percent, PPG is still down 13.04 percent year to date and its 1 year total shareholder return of negative 18.79 percent underlines that momentum has been fading as investors...

Artrya (ASX:AYA) has secured a three year commercial agreement to deploy its Salix platform across Northeast Georgia Health System, providing at least A$300,000 in revenue with additional potential from per scan fees. See our latest analysis for Artrya. The announcement appears to have accelerated an already powerful trend, with a 7 day share price return of 25.56 percent contributing to a 533.87 percent year to date share price return and a 727.37 percent 1 year total shareholder return...